114 related articles for article (PubMed ID: 23877981)
1. Risk of a recurrent cardiovascular event in individuals with type 2 diabetes or intermediate hyperglycemia: the Hoorn Study.
van der Heijden AA; Van't Riet E; Bot SD; Cannegieter SC; Stehouwer CD; Baan CA; Dekker JM; Nijpels G
Diabetes Care; 2013 Nov; 36(11):3498-502. PubMed ID: 23877981
[TBL] [Abstract][Full Text] [Related]
2. Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial.
Verma S; Bain SC; Buse JB; Idorn T; Rasmussen S; Ørsted DD; Nauck MA
JAMA Cardiol; 2019 Dec; 4(12):1214-1220. PubMed ID: 31721979
[TBL] [Abstract][Full Text] [Related]
3. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
4. Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.
Hanssen NMJ; Westerink J; Scheijen JLJM; van der Graaf Y; Stehouwer CDA; Schalkwijk CG;
Diabetes Care; 2018 Aug; 41(8):1689-1695. PubMed ID: 29784769
[TBL] [Abstract][Full Text] [Related]
5. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
[TBL] [Abstract][Full Text] [Related]
6. Diabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes.
Cha SA; Yun JS; Lim TS; Min K; Song KH; Yoo KD; Park YM; Ahn YB; Ko SH
PLoS One; 2016; 11(10):e0164807. PubMed ID: 27741306
[TBL] [Abstract][Full Text] [Related]
7. Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study.
Janssen PG; Gorter KJ; Stolk RP; Akarsubasi M; Rutten GE
BMC Fam Pract; 2008 Dec; 9():67. PubMed ID: 19087327
[TBL] [Abstract][Full Text] [Related]
8. Increased serum calcium levels and risk of type 2 diabetes in individuals at high cardiovascular risk.
Becerra-Tomás N; Estruch R; Bulló M; Casas R; Díaz-López A; Basora J; Fitó M; Serra-Majem L; Salas-Salvadó J
Diabetes Care; 2014 Nov; 37(11):3084-91. PubMed ID: 25139884
[TBL] [Abstract][Full Text] [Related]
9. Parity, weight change, and maternal risk of cardiovascular events.
Klingberg S; Brekke HK; Winkvist A; Engström G; Hedblad B; Drake I
Am J Obstet Gynecol; 2017 Feb; 216(2):172.e1-172.e15. PubMed ID: 27720863
[TBL] [Abstract][Full Text] [Related]
10. [Body mass index, waist circumference and waist-to-height ratio associated with the incidence of type 2 diabetes mellitus: a cohort study].
Yang XY; Zhang M; Luo XP; Wang JJ; Yin L; Pang C; Wang GA; Shen YX; Wu DT; Zhang L; Ren YC; Wang BY; Zhang HY; Zhou JM; Han CY; Zhao Y; Feng TP; Hu DS; Zhao JZ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):328-33. PubMed ID: 27029364
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Recurrent Cardiovascular Events Before Age 65 Years or Within 2.5 Years of a Recent First Cardiovascular Event.
van den Berg MJ; Westerink J; van der Graaf Y; Kappelle LJ; de Borst GJ; Cramer MM; Visseren FLJ;
Am J Cardiol; 2017 Jul; 120(2):167-173. PubMed ID: 28532782
[TBL] [Abstract][Full Text] [Related]
12. Higher blood pressure predicts diabetes and enhances long-term risk of cardiovascular disease events in individuals with impaired glucose tolerance: Twenty-three-year follow-up of the Daqing diabetes prevention study.
Li X; Wang J; Shen X; An Y; Gong Q; Li H; Zhang B; Shuai Y; Chen Y; Hu Y; Li G
J Diabetes; 2019 Jul; 11(7):593-598. PubMed ID: 30556339
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population.
Li S; Peng Y; Wang X; Qian Y; Xiang P; Wade SW; Guo H; Lopez JAG; Herzog CA; Handelsman Y
Clin Cardiol; 2019 Mar; 42(3):391-399. PubMed ID: 30697776
[TBL] [Abstract][Full Text] [Related]
14. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.
Anand SS; Dagenais GR; Mohan V; Diaz R; Probstfield J; Freeman R; Shaw J; Lanas F; Avezum A; Budaj A; Jung H; Desai D; Bosch J; Yusuf S; Gerstein HC;
Eur J Prev Cardiol; 2012 Aug; 19(4):755-64. PubMed ID: 21551215
[TBL] [Abstract][Full Text] [Related]
15. Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience.
Donahue RP; Dorn JM; Stranges S; Swanson M; Hovey K; Trevisan M
Nutr Metab Cardiovasc Dis; 2011 Jul; 21(7):504-11. PubMed ID: 20227262
[TBL] [Abstract][Full Text] [Related]
16. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.
Mozaffarian D; Marfisi R; Levantesi G; Silletta MG; Tavazzi L; Tognoni G; Valagussa F; Marchioli R
Lancet; 2007 Aug; 370(9588):667-75. PubMed ID: 17720018
[TBL] [Abstract][Full Text] [Related]
17. Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.
Kern DM; Mellström C; Hunt PR; Tunceli O; Wu B; Westergaard M; Hammar N
Curr Med Res Opin; 2016; 32(4):703-11. PubMed ID: 26709864
[TBL] [Abstract][Full Text] [Related]
18. Data-driven assessment, contextualisation and implementation of 134 variables in the risk for type 2 diabetes: an analysis of Lifelines, a prospective cohort study in the Netherlands.
van der Meer TP; Wolffenbuttel BHR; Patel CJ
Diabetologia; 2021 Jun; 64(6):1268-1278. PubMed ID: 33710397
[TBL] [Abstract][Full Text] [Related]
19. Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus.
Xing Z; Peng Z; Wang X; Zhu Z; Pei J; Hu X; Chai X
Cardiovasc Diabetol; 2020 Mar; 19(1):39. PubMed ID: 32213183
[TBL] [Abstract][Full Text] [Related]
20. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
